Quercetin-loaded mixed micelles exhibit enhanced cytotoxic efficacy in non-small cell lung cancer in vitro

被引:21
|
作者
Zhao, Ming-Hong [1 ]
Yuan, Lin [1 ]
Meng, Ling-Yun [1 ]
Qiu, Jian-Ling [1 ]
Wang, Chun-Bin [2 ]
机构
[1] Jianhu Peoples Hosp, Dept Oncol, Yancheng 224700, Jiangsu, Peoples R China
[2] Yancheng Third Peoples Hosp, Dept Oncol, 75 Juchang Rd, Yancheng 224001, Jiangsu, Peoples R China
关键词
quercetin; lung cancer; mixed micelles; apoptosis; pH-responsive; DELIVERY; PROLIFERATION; NANOPARTICLES; FLAVONOIDS; APOPTOSIS; THERAPY;
D O I
10.3892/etm.2017.5230
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In the present study, quercetin (QUR) -loaded mixed micelles (QUR-M) were prepared with the aim of improving the physicochemical and anticancer efficacy of QUR in lung cancer cells. The mixed micelles comprised tocopheryl polyethylene glycol 1000 succinate (TPGS) and a 1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine derivative of polyethylene glycol. The nanosized QUR-M exhibited a pH-responsive and controlled release of QUR that is likely to be beneficial in cancer treatment. The results of an MTT assay clearly demonstrated that the anticancer effect of QUR-M in A549 cancer cells was stronger compared with that of free QUR at 24 and 48 h time points. The half-maximal inhibitory concentrations of QUR and QUR-M were observed to be 12.45 and 6.42 mu g/ml, respectively. When stained with Hoechst 33342 and observed using a confocal laser scanning microscope, A549 cells treated with QUR-M exhibited severe chromatin condensation and apoptotic body formation of the nuclei. Overall, high intracellular uptake, sustained drug release and the presence of TPGS in the mixed micelles may result in an increased inhibitory effect against cell proliferation and improved therapeutic efficacy in lung cancers.
引用
收藏
页码:5503 / 5508
页数:6
相关论文
共 50 条
  • [41] Engineering docetaxel-loaded micelles for non-small cell lung cancer: a comparative study of microfluidic and bulk nanoparticle preparation
    Bao, Yuchen
    Deng, Qinfang
    Li, Yongyong
    Zhou, Songwen
    RSC ADVANCES, 2018, 8 (56) : 31950 - 31966
  • [42] MIXED SMALL CELL AND NON-SMALL CELL LUNG-CANCER - INCIDENCE AND CLINICAL BEHAVIOR
    ADELSTEIN, DJ
    TOMASHEFSKI, JF
    SNOW, NJ
    HORRIGAN, TP
    HINES, JD
    CLINICAL RESEARCH, 1984, 32 (04): : A798 - A798
  • [43] Erlotinib-Cyclodextrin Complex Loaded Biodegradable Nanoparticles For Enhanced Anti-Proliferative Efficacy Against Non-Small Cell Lung Cancer
    Gupta, V.
    Vaidya, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [44] Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells
    Huang, Guojin
    Zang, Bao
    Wang, Xiaowei
    Liu, Gang
    Zhao, Jianqiang
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2015, 47 (12) : 981 - 987
  • [45] The Importance of Suppressor and Cytotoxic T Lymphocyte Subsets and Cytotoxic Mechanisms in Non-Small Cell Lung Cancer
    Turna, A.
    Aktas, E.
    Engin, A.
    Cikman, D.
    Ayan, G.
    Deniz, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S528 - S529
  • [46] Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines
    Carolina Martinez-Torres, Ana
    Gomez-Morales, Luis
    Martinez-Loril, Alan B.
    Concepcion Uscanga-Palomeque, Ashanti
    Manuel Vazquez-Guillen, Jose
    Rodriguez-Padilla, Cristina
    PEERJ, 2019, 7
  • [47] Highly in vitro anti-cancer activity of melittin-loaded niosomes on non-small cell lung cancer cells
    Honari, Pooyan
    Shahbazzadeh, Delavar
    Behdani, Mahdi
    Bagheri, Kamran Pooshang
    TOXICON, 2024, 241
  • [48] In vitro and in vivo antitumor efficacy of the sequentially combined vinorelbine and gefitinib in Non-Small Cell Lung Cancer cell lines
    Barletta, G.
    Genova, C.
    Rijavec, E.
    Biello, F.
    Maggioni, C.
    Dal Bello, M. G.
    Alama, A.
    Coco, S.
    Vanni, I.
    Truini, A.
    Sambuceti, G.
    Grossi, F.
    ANNALS OF ONCOLOGY, 2015, 26 : 82 - 82
  • [49] In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non-small cell lung cancer cell lines
    Wang, Min-Cong
    Liang, Xuan
    Liu, Zhi-Yan
    Cui, Jie
    Liu, Ying
    Jing, Li
    Jiang, Li-Li
    Ma, Jie-Qun
    Han, Li-Li
    Guo, Qian-Qian
    Yang, Cheng-Cheng
    Wang, Jing
    Wu, Tao
    Nan, Ke-Jun
    Yao, Yu
    ONCOLOGY REPORTS, 2015, 33 (01) : 239 - 249
  • [50] Advances in cytotoxic chemotherapy for the treatment of metastatic or recurrent non-small cell lung cancer
    Milton, DT
    Miller, VA
    SEMINARS IN ONCOLOGY, 2005, 32 (03) : 299 - 314